Co-delivery of chemotherapeutics and proteins for synergistic therapy.

Co-delivery of chemotherapeutics and proteins for synergistic therapy.

Item
http://www.wikidata.org/entity/Q38627486
Co-delivery nanoparticles with characteristics of intracellular precision release drugs for overcoming multidrug resistance.Recent progress in nanomedicine-based combination cancer therapy using a site-specific co-delivery strategy.Organic nanoparticle systems for spatiotemporal control of multimodal chemotherapy.Delivery of therapeutics with nanoparticles: what's new in cancer immunotherapy?Repurposing platinum-based chemotherapies for multi-modal treatment of glioblastoma.Liposome-targeted delivery for highly potent drugs.Multifunctionalized polyethyleneimine-based nanocarriers for gene and chemotherapeutic drug combination therapy through one-step assembly strategy.Co-delivery nanoparticles of anti-cancer drugs for improving chemotherapy efficacy.Achieving High Drug Loading and Sustained Release of Hydrophobic Drugs in Hydrogels through In Situ Crystallization.Co-delivery of Aurora-A inhibitor XY-4 and Bcl-xl siRNA enhances antitumor efficacy for melanoma therapy.Trojan‐Horse‐Like Stimuli‐Responsive Microcapsules.
P2860

Co-delivery of chemotherapeutics and proteins for synergistic therapy.

Item
http://www.wikidata.org/entity/Q38627486
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Co-delivery of chemotherapeutics and proteins for synergistic therapy.
@en
type
label
Co-delivery of chemotherapeutics and proteins for synergistic therapy.
@en
prefLabel
Co-delivery of chemotherapeutics and proteins for synergistic therapy.
@en
P1433
P1476
P2093
P304
P31
P356
P407
P478
P50
P577
P698
P921
P356
P1433
P1476
Co-delivery of chemotherapeutics and proteins for synergistic therapy
@en
P2093
P304
P31
P356
10.1016/J.ADDR.2015.10.021
P407
P478
P50
P577
P698
P921